Coming Soon: Generic Glucagon Rescue
Xeris gets $41M for shelf-stable glucagon pen
Zegalogue: A New Easy-to-Use Diabetes Rescue Glucagon
FDA Approves Potentially Life Saving GVOKE: Xeris' Ready-to-Use Glucagon | diaTribe
Xeris Pharma Announces FDA to Review NDA for Its Ready-to-Use Glucagon Rescue Pen | dLife
A Demand for Better Glucagon Products and Policy
Xeris Pharmaceuticals Is An Attractive Buy Opportunity In 2018 (NASDAQ:XERS) | Seeking Alpha
New Glucagon Rescue Pen: Gvoke HypoPen - Diabetes Self-Management
Glucagon Rescue Meds and PocketCard - Diabetes Education Services
Xeris: Preparing For The Gvoke PDUFA (NASDAQ:XERS) | Seeking Alpha
Xeris scores first FDA nod with shelf-stable glucagon injector, syringe | FiercePharma
Ready-to-use glucagon rescue pen - Type 1 and LADA - TuDiabetes Forum
Xeris: Looking For Entry Before PDUFA (NASDAQ:XERS) | Seeking Alpha
Next-Gen Emergency Glucagon: Xeris to the Rescue? | Type one diabetes, Diabetes supplies, Diabetes
Xeris' glucagon injection Gvoke gains heat with HypoPen auto-injector launch | FiercePharma
Two New Glucagon Formulations Await FDA Approval in 2019 — Healthy Living Medical Supply
S-1/A
Next-Gen Emergency Glucagon: Xeris to the Rescue? | Diabetes technology, Diabetes diet plan, Diabetes management
In the Know with GVOKE: Conversations about Severe Low Blood Sugar and New Treatment Options – Greater New York City Chapter
xeriscanaccordaug2018fin
Glucagon Rescue Meds and PocketCard - Diabetes Education Services
